Find clinical trials for Melanoma in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Hanyang, Seoul, KOR:
(PK) similarity and efficacy, safety, and immunogenicity of ABP 206 compared with OPDIVO® (nivolumab) in subjects with resected advanced melanoma...
Phase 3
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea and 79 other locations
alone in participants with untreated, unresectable or metastatic melanoma. Participants randomized to the pembrolizumab monotherapy arm who ...
Phase 3
Seoul, Korea, Republic of and 71 other locations
of ceralasertib, when administered as monotherapy and in combination with durvalumab in participants with unresectable or advanced melanoma ...
Phase 2
Seoul, Korea, Republic of and 65 other locations
assess the efficacy, safety, and immunogenicity of ABP 206 compared with Nivolumab in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma...
Phase 3
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea and 186 other locations
combined with nivolumab in patients with unresectable or metastatic melanoma. A separate open-label cohort of adults with new, progressive b...
Phase 3
Seoul, South Korea and 138 other locations
(PK) similarity and efficacy, safety, and immunogenicity of GME751 compared with Keytruda® (pembrolizumab) in subjects with resected advanced melanoma...
Phase 1
Seoul, Korea, Republic of and 61 other locations
belvarafenib as a single agent and in combination with either cobimetinib or cobimetinib plus nivolumab in patients with NRAS-mutant advanced melanoma...
Phase 1
Seoul, South Korea and 15 other locations
is safe and prevents cancer from returning in people with high-risk melanoma. Researchers want to know if intismeran autogene with pembroliz...
Phase 3
Seoul, South Korea and 166 other locations
Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood ca...
Phase 1, Phase 2
Seoul, Korea, Republic of and 16 other locations
tumors (including but not limited to head and neck cancer, malignant melanoma, CRC, renal cell carcinoma, cervical cancer, and breast cancer...
Phase 1, Phase 2
Seoul, Korea, Republic of and 3 other locations
Clinical trials
Research sites
Resources
Legal